Global Metabolomics Market 2022-2028

June 2022 | 74 pages | ID: G4563062BBA2EN
Gen Consulting Company

Abstracts

Metabolomics is an analytical profiling technique for measuring and comparing large numbers of metabolites present in biological samples. Combining high-throughput analytical chemistry and multivariate data analysis, metabolomics offers a window on metabolic mechanisms. The global metabolomics market is anticipated to increase by USD 12 billion till 2028 at an average annual growth of 11.8 percent as per the latest report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global metabolomics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the metabolomics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, indication, application, and region. The global market for metabolomics can be segmented by product: assays, bioinformatics, detection techniques, separation techniques. The separation techniques segment is estimated to account for the largest share of the global metabolomics market. Metabolomics market is further segmented by indication: cancer, cardiovascular disorders, inborn errors of metabolism, neurological disorders, others. The cancer segment held the largest revenue share in 2021. Based on application, the metabolomics market is segmented into: biomarker discovery, drug discovery, functional genomics, nutrigenomics, toxicology testing, others. Globally, the biomarker discovery segment made up the largest share of the metabolomics market. On the basis of region, the metabolomics market also can be divided into: Asia Pacific, Europe, North America, MEA (Middle East and Africa), Latin America. North America was the largest contributor to the global metabolomics market in 2021.

By product:

• assays
• bioinformatics
• detection techniques
• separation techniques

By indication:

• cancer
• cardiovascular disorders
• inborn errors of metabolism
• neurological disorders
• others

By application:

• biomarker discovery
• drug discovery
• functional genomics
• nutrigenomics
• toxicology testing
• others

By region:

• Asia Pacific
• Europe
• North America
• MEA (Middle East and Africa)
• Latin America

The separation techniques market is further segmented into capillary electrophoresis, gas chromatography, liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography). The liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography) segment held the largest share of the global metabolomics market in 2021 and is anticipated to hold its share during the forecast period. Furthermore, the detection techniques market has been categorized into mass spectrometry, multivariate analysis, spectroscopy (NMR and FTIR). In 2021, the mass spectrometry segment made up the largest share of revenue generated by the metabolomics market.

The market research report covers the analysis of key stake holders of the global metabolomics market. Some of the leading players profiled in the report include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, LECO Corporation, Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global metabolomics market.
• To classify and forecast the global metabolomics market based on product, indication, application, region.
• To identify drivers and challenges for the global metabolomics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global metabolomics market.
• To identify and analyze the profile of leading players operating in the global metabolomics market.

Why Choose This Report

• Gain a reliable outlook of the global metabolomics market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Assays
Bioinformatics
Detection techniques
Separation techniques

PART 6. MARKET BREAKDOWN BY INDICATION

Cancer
Cardiovascular disorders
Inborn errors of metabolism
Neurological disorders
Others

PART 7. MARKET BREAKDOWN BY APPLICATION

Biomarker discovery
Drug discovery
Functional genomics
Nutrigenomics
Toxicology testing
Others

PART 8. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
MEA (Middle East and Africa)
Latin America

PART 9. KEY COMPANIES

Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Bruker Corporation
Danaher Corporation
LECO Corporation
Metabolon Inc.
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Waters Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER